While our study focused on the association between platelet activation and psychiatric disorders, the lack of significant associations with other markers of inflammation, such as CRP, suggests a unique relationship between platelet activation and psychiatric outcomes in the context of COVID-19. This evidence concerns the gene CRP and psychiatric disorder.